Patterson Joshua F. 4
4 · AKCEA THERAPEUTICS, INC. · Filed Oct 13, 2020
Insider Transaction Report
Form 4
Patterson Joshua F.
General Counsel
Transactions
- Disposition from Tender
Common Stock
2020-10-12$18.15/sh−26,532$481,556→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$1.16/sh−13,750$15,950→ 0 totalExercise: $16.99Exp: 2030-01-01→ Common Stock (13,750 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.39/sh−7,500$40,425→ 0 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]This option, which provided that 1/4th of the shares would vest one year after January 2, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $15,950.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
- [F2]This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $40,425.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.